| Products |
Mandatory Standard |
Quality Control Items |
Bromadiolone
(Issued:1st-Sep-2006) |
GB20778-2006 GB20679-2006 |
Technical:Active Ingredient≥97%; Ratio of Cis-trans isomer(A:B)≤0.30; PH:5.0-9.0; Weight loss on heating≤1.0%
0.5% concentrates Liquid: Active Ingredient≥0.5%; Ratio of Cis-trans isomer(A:B)≤0.30; PH:6.0-9.0;Moisture≤3.0%;Fineness(through 45m pore diameter seive)≥96%.
0.5% concentrates Powder:Active Ingredient≥0.5%; Ratio of Cis-trans isomer(A:B)≤0.30; PH:8.0-11.0. |
Brodifacoum
(Issued:24-Aug-2006) |
GB20690-2006
GB20687-2006
|
Technical:Active Ingredient≥95%; Ratio of Cis-trans isomer(A:B):1.0-4.0;
PH:4.0-8.0; Weight loss on heating≤1.0;Acetone Insoluble≤0.5%
0.5% Concentrates:Active Ingredient≤0.5%; Ratio of Cis-trans isomer(A:B):1.0-4.0;PH:7.0-11.0 |
| Difenacoum |
Q/321323 SZ 08-2002 |
Active Ingredient≥96.0%; PH:5.0-8.0; Weigth loss
after heating≤1.5%; Insoluble≤1.0% |
| Warfarin |
Q/321323 sz11-2006 |
Active Ingredient≥98%;Weight loss on heating≤ 1.5%;PH:6.0-9.0;Acetone Insoluble≤0.5% |
| Chlorophacinone |
Enterprise standard |
Active Ingredient≥97%; Inorganic-Salt≤0.3%;
Dimethy1 phthalate≤0.2% |
| Coumatetralyl |
Q/321323 SZ12-2006 |
Active Ingredient≥96%;Weight loss on heating≤1.5%;PH:6.0-9.0;Acetone Insoluble≤0.5%
|